FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutical industry, in particular to method of obtaining system of targeted drug delivery for introduction of pharmaceutically active substance into central nervous system of mammals through hematoencephalic barrier. System contains poly(DL-lactide) and/or poly(DL-lactide-soglycolide)-based nanoparticles, pharmacologically active substance, absorbed, adsorbed and/or included into nanoparticles, and contains TPGS or has coating from surface-active substance pluronic 188, which is precipitated on drug-filled nanoparticles. Described are methods of obtaining system of targeted drug delivery and application of system of targeted drug delivery for treatment of CNS disease or disorder.
EFFECT: elaboration of efficient method of obtaining system of targeted drug delivery for introduction of pharmacologically active substance into central nervous system of mammals through hematoencephalic barrier.
20 cl, 14 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING A POLYMER-CONTAINING SILYBIN COMPOSITION | 2019 |
|
RU2716706C1 |
DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2005 |
|
RU2390355C2 |
VECTORIZED WATER-COMPATIBLE POLYMER MICELLAR PARTICLES FOR DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES THROUGH BLOOD-BRAIN BARRIER | 2020 |
|
RU2752177C1 |
METHOD FOR DELIVERING NANOPARTICLES INTENDED FOR THE TRANSPORT OF DRUGS TO THE BRAIN OF MAMMALS THROUGH THE BLOOD-BRAIN BARRIER | 2017 |
|
RU2670091C1 |
METHOD OF PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING PENTOXIFYLLINE | 2017 |
|
RU2702012C2 |
BIODEGRADABLE, SEMI-CRYSTALLINE, PHASE SEPARATED, THERMOPLASTIC MULTI-BLOCK COPOLYMERS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2012 |
|
RU2662818C2 |
PROLONGED RELEASE FORMULATION CONTAINING OCTREOTIDE AND THREE LINEAR POLYMERS OF POLY(LACTIDE-CO-GLYCOLIC ACID) | 2009 |
|
RU2541104C2 |
METHOD OF OBTAINING POLY-DL-LACTIDE-CO-GLYCOLIDE NANOPARTICLES WITH INCAPSULATED IN THEM ANTITUBERCULOSIS MEDICATIONS | 2005 |
|
RU2396945C2 |
POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
DRUG OF ANTI-TUBERCULOSIS ACTION ON THE BASIS OF D-CYCLOSERINE IN THE FORM OF A LYOPHILISATE AND METHOD OF PRODUCING A MEDICINAL PREPARATION | 2015 |
|
RU2606839C1 |
Authors
Dates
2011-07-10—Published
2007-03-13—Filed